The company had sold 14,214 units in the same month last year, Kia India said in a statement.
The company had dispatched 10,480 units to its dealers in the same month last year, Ashok Leyland said in a statement.
The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) of diclofenac sodium topical solution is for strength of 2 per cent, the company said in a statement.
The PSU had produced 353.4 MT in the April-November period of the last financial year.
The company had dispatched 46,910 units to dealers in the same month last year.
The automaker had dispatched 5,605 units in November 2021.
The company had sold 13,003 units in the domestic market in the year-ago period.
The project loan facility is supported by MUFG Bank and Sumitomo Mitsui Banking Corporation with equal participation, a company statement said.
The company said it has received the final approval from the US Food and Drug Administration (USFDA) to market the product in multiple strengths.
The amount to be raised will be used for expansion of operations across different markets, and to scale up the platform and its AI Labs initiative.
The company had sold 2,196 units in the same month last year.
Total sales in the domestic market stood at 1,52,716, down 4 percent from 1,58,755 units in the same month last year, the company said in a regulatory filing.
The automaker had sold 2,481 units in the same month last year.
In a statement, DeHaat said "it has raised USD 60 million in a new financing round." Sofina Ventures and Temasek co-led the Series E funding, with other existing investors RTP Global Partners, Prosus Ventures and Lightrock India also participating in the round.
Singapore Airlines (SIA), which commenced services to India more than 50 years ago, expects to immediately gain exposure to an entity that is four to five times larger in scale post the merger.
The young engineers will join the company in 2023, and will work on new-age technologies at its R&D institutes in Bengaluru, Noida, Delhi and at Samsung Semiconductor India Research in Bengaluru.
India is a fundamentally strong long-term growth story. Therefore, every opportunity should be used to buy on decline and not sell on rally
CCL is targeting more than 40 percent growth in FY23 in the domestic market on the back of higher distribution in south and north India.
The private equity firm has been sounding out financing for a potential deal that could value Tower Vision India at about $300 million to $400 million, said the people, who asked not to be identified discussing private information.
KSSF timely infusion is aimed at correcting SIL's capital structure, help the company’s liquidity profile, and enhance its operations.
VIL’s growth has been supported by the upgradation of its product portfolio and newer market coverage
The company said it is exiting meal deliveries as well as a service providing bulk doorstep deliveries of packaged consumer goods to small businesses.
The company's decision to invest will empower Upakarma Ayurveda to develop a wider range of products and offerings, the drug firm said in a statement.
The company's US-based unit has received tentative approval from the US Food and Drug Administration (USFDA) to market the medication, the drug firm said in a regulatory filing.
The transaction is expected to be concluded in the next fortnight, Max Financial Services Ltd (MFSL) said in a regulatory filing.